Form 4: Aethlon Medical Director Forfeits Shares for Tax

Aethlon Medical Director Edward G. Broenniman forfeited 89 shares of common stock to cover tax withholdings related to restricted stock unit conversion.

Summary

• Edward G. Broenniman, a Director at Aethlon Medical Inc. (AEMD), forfeited 89 shares of common stock.
• The forfeiture occurred on December 31, 2025, at a market price of $2.77 per share.
• This action was taken to cover tax withholdings upon the conversion of an aggregate of 357 vested and outstanding restricted stock units (RSUs) into common stock.
• Following this transaction, Mr. Broenniman directly beneficially owns 2,807 shares of AEMD common stock.
• The original RSU grant was previously reported in a Form 4 filed on April 25, 2025.

Sentiment

Score: 5

Explanation: The transaction is a neutral, non-discretionary event related to tax obligations from RSU vesting, carrying no inherent positive or negative sentiment for the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine insider transaction related to equity compensation and tax obligations, which is common across all industries for publicly traded companies with RSU programs. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and represents a very small percentage of outstanding shares. It does not indicate a change in the director's overall commitment or view of the company.
• Employees: No direct impact on employees.

Key Dates

Keywords

AEMD, Aethlon Medical, Form 4, Insider Transaction, Stock Forfeiture, RSU, Tax Withholding, Director